The function of Golgi apparatus in LRRK2-associated Parkinson's disease

被引:4
|
作者
Wei, Yonghang [1 ]
Awan, Maher un Nisa [1 ]
Bai, Liping [1 ]
Bai, Jie [1 ]
机构
[1] Kunming Univ Sci & Technol, Med Sch, Lab Mol Neurobiol, Kunming, Peoples R China
来源
FRONTIERS IN MOLECULAR NEUROSCIENCE | 2023年 / 16卷
基金
中国国家自然科学基金;
关键词
Parkinson's; LRRK2; Rab29; VPS52; PKC; Golgi apparatus; ANIMAL-MODELS; LRRK2; KINASE; FRAGMENTATION; PROTEINS; PHOSPHORYLATION; TRAFFICKING; RAB; MUTATIONS; TRANSPORT;
D O I
10.3389/fnmol.2023.1097633
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Parkinson's disease (PD) is a chronic neurodegenerative disease associated with the intracellular organelles. Leucine-rich repeat kinase 2 (LRRK2) is a large multi-structural domain protein, and mutation in LRRK2 is associated with PD. LRRK2 regulates intracellular vesicle transport and function of organelles, including Golgi and lysosome. LRRK2 phosphorylates a group of Rab GTPases, including Rab29, Rab8, and Rab10. Rab29 acts in a common pathway with LRRK2. Rab29 has been shown to recruit LRRK2 to the Golgi complex (GC) to stimulate LRRK2 activity and alter the Golgi apparatus (GA). Interaction between LRRK2 and Vacuolar protein sorting protein 52 (VPS52), a subunit of the Golgi-associated retrograde protein (GARP) complex, mediates the function of intracellular soma trans-Golgi network (TGN) transport. VPS52 also interacts with Rab29. Knockdown of VPS52 leads to the loss of LRRK2/Rab29 transported to the TGN. Rab29, LRRK2, and VPS52 work together to regulate functions of the GA, which is associated with PD. We highlight recent advances in the roles of LRRK2, Rabs, VPS52, and other molecules, such as Cyclin-dependent kinase 5 (CDK5) and protein kinase C (PKC) in the GA, and discuss their possible association with the pathological mechanisms of PD.
引用
收藏
页数:8
相关论文
共 50 条
  • [11] Cognitive dysfunction in Tunisian LRRK2 associated Parkinson's disease
    Ben Sassi, Samia
    Nabli, Fatma
    Hentati, Emna
    Nahdi, Houda
    Trabelsi, Meriam
    Ben Ayed, Hela
    Amouri, Rim
    Duda, John Eric
    Farrer, Matthew John
    Hentati, Faycal
    PARKINSONISM & RELATED DISORDERS, 2012, 18 (03) : 243 - 246
  • [12] Age at Onset in LRRK2-Associated PD is Modified by SNCA Variants
    Botta-Orfila, Teresa
    Ezquerra, Mario
    Pastor, Pau
    Fernandez-Santiago, Ruben
    Pont-Sunyer, Claustre
    Compta, Yaroslau
    Lorenzo-Betancor, Oswaldo
    Samaranch, Lluis
    Jose Marti, Maria
    Valldeoriola, Francesc
    Calopa, Matilde
    Fernandez, Manel
    Aguilar, Miquel
    de Fabregas, Oriol
    Hernandez-Vara, Jorge
    Tolosa, Eduard
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2012, 48 (01) : 245 - 247
  • [13] LRRK2 interactions with α-synuclein in Parkinson's disease brains and in cell models
    Guerreiro, Patricia Silva
    Huang, Yue
    Gysbers, Amanda
    Cheng, Danni
    Gai, Wei Ping
    Outeiro, Tiago Fleming
    Halliday, Glenda Margaret
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2013, 91 (04): : 513 - 522
  • [14] An Update on the Interplay between LRRK2, Rab GTPases and Parkinson's Disease
    Komori, Tadayuki
    Kuwahara, Tomoki
    BIOMOLECULES, 2023, 13 (11)
  • [15] Rab29 activation of the Parkinson's disease-associated LRRK2 kinase
    Purlyte, Elena
    Dhekne, Herschel S.
    Sarhan, Adil R.
    Gomez, Rachel
    Lis, Pawel
    Wightman, Melanie
    Martinez, Terina N.
    Tonelli, Francesca
    Pfeffer, Suzanne R.
    Alessi, Dario R.
    EMBO JOURNAL, 2018, 37 (01) : 1 - 18
  • [16] Sequential screening nominates the Parkinson's disease associated kinase LRRK2 as a regulator of Clathrin-mediated endocytosis
    Heaton, George R.
    Landeck, Natalie
    Mamais, Adamantios
    Nalls, Mike A.
    Nixon-Abell, Jonathon
    Kumaran, Ravindran
    Beilina, Alexandra
    Pellegrini, Laura
    Li, Yan
    Harvey, Kirsten
    Cookson, Mark R.
    NEUROBIOLOGY OF DISEASE, 2020, 141
  • [17] GTP binding regulates cellular localization of Parkinson's disease-associated LRRK2
    Blanca Ramirez, Marian
    Lara Ordonez, Antonio Jesus
    Fdez, Elena
    Madero-Perez, Jesus
    Gonnelli, Adriano
    Drouyer, Matthieu
    Chartier-Harlin, Marie-Christine
    Taymans, Jean-Marc
    Bubacco, Luigi
    Greggio, Elisa
    Hilfiker, Sabine
    HUMAN MOLECULAR GENETICS, 2017, 26 (14) : 2747 - 2767
  • [18] LRRK2 pathobiology in Parkinson's disease
    Martin, Ian
    Kim, Jungwoo Wren
    Dawson, Valina L.
    Dawson, Ted M.
    JOURNAL OF NEUROCHEMISTRY, 2014, 131 (05) : 554 - 565
  • [19] LRRK2 and Parkinson's Disease: From Lack of Structure to Gain of Function
    Blanca Ramirez, Marian
    Madero-Perez, Jesus
    Rivero-Rios, Pilar
    Martinez-Salvador, Mar
    Lara Ordonez, Antonio J.
    Fernandez, Belen
    Fdez, Elena
    Hilfiker, Sabine
    CURRENT PROTEIN & PEPTIDE SCIENCE, 2017, 18 (07) : 677 - 686
  • [20] LRRK2 links genetic and sporadic Parkinson's disease
    Kluss, Jillian H.
    Mamais, Adamantios
    Cookson, Mark R.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2019, 47 : 651 - 661